GS
Gilead Sciences Portfolio holdings
AUM
$1.28B
1 Year Est. Return
–
AUM
$1.18B
AUM Growth
-$370M
(-24%)
Holding
16
Top Sells
| 1 | +$1.09M | |
| 2 | +$635K | |
| 3 | +$244K | |
| 4 |
KRON
Kronos Bio
KRON
|
+$179K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Arcellx
ACLX
$5.01B
| $441M | 37.32% |
6,720,803
|
|
||
2
Galapagos
GLPG
$2.09B
| $419M | 35.5% |
16,707,477
|
|
||
3
Arcus Biosciences
RCUS
$2.1B
| $247M | 20.88% |
31,424,760
+1,363,636
|
|
||
4
Assembly Biosciences
ASMB
$483M
| $21.1M | 1.79% |
2,209,471
|
|
||
5
Merus
MRUS
$7.19B
| $19M | 1.61% |
452,527
|
|
||
6
Kyverna Therapeutics
KYTX
$301M
| $7.96M | 0.67% |
4,126,119
|
|
||
7
Tango Therapeutics
TNGX
$1.07B
| $6.65M | 0.56% |
4,854,443
|
|
||
8
Xilio Therapeutics
XLO
$41.3M
| $6.6M | 0.56% |
9,105,451
|
|
||
|
KLRS
9
Kalaris Therapeutics
KLRS
$94.1M
| $5.81M | 0.49% |
723,273
|
|
||
|
HOOK
10
DELISTED
HOOKIPA Pharma
HOOK
| $2.03M | 0.17% |
1,875,945
|
|
||
11
Allogene Therapeutics
ALLO
$275M
| $1.69M | 0.14% |
1,156,689
|
|
||
12
Leap Therapeutics
LPTX
$25.3M
| $1.62M | 0.14% |
5,319,148
|
|
||
|
IMA
13
ImageneBio Inc
IMA
$97.4M
| $1.48M | 0.13% |
96,595
-70,767
|
|
||
|
BRNS
14
Barinthus Biotherapeutics
BRNS
$53.9M
| $360K | 0.03% |
369,855
-250,496
|
|
||
|
AGEN
15
Agenus
AGEN
$127M
| – | – |
-231,663
|
|
||
|
KRON
16
DELISTED
Kronos Bio
KRON
| – | – |
-188,567
|
|